MedCity News December 19, 2024
Frank Vinluan

Applications of SandboxAQ’s large quantitative models (LQMs) technology include running simulations that identify new biomarkers and optimize clinical development of drug candidates. The company spun out of Alphabet in 2022.

Artificial intelligence technology company SandboxAQ has raised $300 million to accelerate development of technologies with applications in a range of industries, including the life sciences.

Palo Alto, California-based SandboxAQ, a spinout of Alphabet, specified that the new funding announced Wednesday will support development of large quantitative models (LQMs), which are models that process and analyze large datasets. That’s in contrast to large language models (LLMs) that analyze text.

SandboxAZ says its LQMs are used by companies in the life sciences, energy, financial services, government, telecommunications, and more. In drug research,...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Biotechnology, Investments, Pharma, Pharma / Biotech, Technology, Trends
OpenAI CEO Sam Altman: Company Considering ‘Different Open-Source Strategy’
Chinese AI app DeepSeek was downloaded by millions. Deleting it might come next
Forget Billion-Dollar Companies—Will AI Create Billion-Dollar People?
Reid Hoffman enters 'wondrous and terrifying' world of health care with latest AI startup
The future of cardiac monitoring: AI-powered wearables in practice

Share This Article